MedTrace Logo

SeOuL cOhort of Brain Tumor MONitoring Study (SOLOMON)

NCT05254197 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2024-12-03

No results posted yet for this study

Summary

The registry of this study was subjected to patients who were radiologically diagnosed with a non-malignant brain tumor at Seoul National University Hospital since 2001, and who have had magnetic resonance (MR) re-examination after first MR exam or will be re-examined because it was determined that immediate treatment would not be needed at the first visit to the hospital. In all MRs taken by patients, the date of imaging and the volume of the tumor are measured, and we aim to establish a natural growth history for non-malignant brain tumors.

Conditions

  • Brain Tumor, Primary
  • Meningioma
  • Schwannoma
  • Pituitary Adenoma
  • Gliomas Benign

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Chul-Kee Park, MD PhD · Seoul National University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-01-01
Primary Completion
2035-12-31
Completion
2035-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05254197 on ClinicalTrials.gov